{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:20:17Z","timestamp":1793035217676,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.beem.2021.101487","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T02:19:39Z","timestamp":1611109179000},"page":"101487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Medical therapy in severe hypercortisolism"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5610-9564","authenticated-orcid":false,"given":"J\u00falia Vieira Oberger","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-7941","authenticated-orcid":false,"given":"Cesar Luiz","family":"Boguszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9996","key":"10.1016\/j.beem.2021.101487_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019 s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.beem.2021.101487_bib2","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of cushing\u2019s syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib3","doi-asserted-by":"crossref","first-page":"101382","DOI":"10.1016\/j.beem.2020.101382","article-title":"Cushing\u2019s syndrome - disease monitoring: recurrence, surveillance with biomarkers or imaging studies","volume":"34","author":"Ragnarsson","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"issue":"1","key":"10.1016\/j.beem.2021.101487_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.20945\/2359-3997000000014","article-title":"A\u00a0review of cushing\u2019s disease treatment by the department of neuroendocrinology of the Brazilian society of endocrinology and metabolism","volume":"62","author":"Machado","year":"2018","journal-title":"Arch Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12020-016-0914-9","article-title":"The degree of urinary hypercortisolism is not correlated with the severity of cushing\u2019s syndrome","volume":"55","author":"Guarnotta","year":"2017","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.beem.2021.101487_bib6","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/EJE-19-0877","article-title":"Management OF endocrine disease: cushing\u2019s syndrome due to ectopic ACTH secretion: an expert operational opinion","volume":"182","author":"Young","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2021.101487_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40265-016-0539-6","article-title":"Therapeutic strategies for the treatment of severe cushing\u2019s syndrome","volume":"76","author":"Alexandraki","year":"2016","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.beem.2021.101487_bib8","article-title":"Disseminated strongyloides stercoralis infection associated with endogenous hypercortisolism - a case report","volume":"7","author":"Lemos Cabral","year":"2020","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.beem.2021.101487_bib9","first-page":"17","article-title":"Severe Cushing\u2019s syndrome and bilateral pulmonary nodules: beyond ectopic ACTH","volume":"2017","author":"Tavares Bello","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3803\/EnM.2018.33.2.139","article-title":"Recent updates on the diagnosis and management of cushing\u2019s syndrome","volume":"33","author":"Nieman","year":"2018","journal-title":"Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ecl.2018.02.008","article-title":"Cushing\u2019s syndrome in pediatrics: an update","volume":"47","author":"Lodish","year":"2018","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.12259","article-title":"High variability in baseline urinary free cortisol values in patients with Cushing\u2019s disease","volume":"80","author":"Petersenn","year":"2014","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2021.101487_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s12020-018-1818-7","article-title":"The medical treatment with pasireotide in Cushing\u2019s disease: an Italian multicentre experience based on \"real-world evidence","volume":"64","author":"Pivonello","year":"2019","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.beem.2021.101487_bib14","first-page":"42","article-title":"Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin","volume":"85","author":"Sarlis","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2021.101487_bib15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1507\/endocrj.K09E-198","article-title":"Hypokalemia, diabetes mellitus, and hypercortisolemia are the major contributing factors to cardiac dysfunction in adrenal Cushing\u2019s syndrome","volume":"56","author":"Takagi","year":"2009","journal-title":"Endocr J"},{"issue":"4","key":"10.1016\/j.beem.2021.101487_bib16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000012396","article-title":"A\u00a0clinical index for rating severity in Cushing\u2019s syndrome","volume":"69","author":"Sonino","year":"2000","journal-title":"Psychother Psychosom"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib17","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/ERC-15-0541","article-title":"Bilateral adrenalectomy in the 21st century: when to use it for hypercortisolism?","volume":"23","author":"Guerin","year":"2016","journal-title":"Endocr Relat Canc"},{"issue":"10","key":"10.1016\/j.beem.2021.101487_bib18","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Clinical review: outcome of bilateral adrenalectomy in Cushing\u2019s syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.surg.2020.03.019","article-title":"Adrenalectomy during pregnancy: a 15-year experience at a tertiary referral center","volume":"168","author":"Gaujoux","year":"2020","journal-title":"Surgery"},{"issue":"766","key":"10.1016\/j.beem.2021.101487_bib20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/pgmj.65.766.575","article-title":"Use of adrenal arterial embolization in severe ACTH-dependent Cushing\u2019s syndrome","volume":"65","author":"Blunt","year":"1989","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.beem.2021.101487_bib21","first-page":"100","article-title":"Transcatheter adrenal arterial embolization of cortisol-producing tumors. Two cases of Cushing\u2019s syndrome","volume":"40","author":"Ueno","year":"1999","journal-title":"Acta Radiol"},{"issue":"1","key":"10.1016\/j.beem.2021.101487_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2214\/AJR.12.9507","article-title":"Adrenal artery embolization: anatomy, indications, and technical considerations","volume":"201","author":"Fowler","year":"2013","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.beem.2021.101487_bib23","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2015-2616","article-title":"Effectiveness of metyrapone in treating cushing\u2019s syndrome: a retrospective multicenter study in 195 patients","volume":"100","author":"Daniel","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2021.101487_bib24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing\u2019s disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2021.101487_bib25","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1530\/EJE-18-0694","article-title":"Should we avoid using ketoconazole in patients with severe Cushing\u2019 s syndrome and increased levels of liver enzymes?","volume":"179","author":"Ollivier","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2021.101487_bib26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/00003246-200103000-00039","article-title":"Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients","volume":"29","author":"Albert","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.beem.2021.101487_bib27","first-page":"150027","article-title":"Fluconazole and acetazolamide in the treatment of ectopic Cushing\u2019s syndrome with severe metabolic alkalosis","volume":"2015","author":"Schwetz","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11102-011-0314-3","article-title":"Medical suppression of hypercortisolemia in Cushing\u2019s syndrome with particular consideration of etomidate","volume":"15","author":"Heyn","year":"2012","journal-title":"Pituitary"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-12-0274","article-title":"Etomidate in the management of hypercortisolaemia in Cushing\u2019s syndrome: a review","volume":"167","author":"Preda","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2021.101487_bib30","first-page":"1","article-title":"Continuous etomidate infusion for the management of severe cushing syndrome: validation of a standard protocol","volume":"3","author":"Carroll","year":"2018","journal-title":"J\u00a0Endocr Soc"},{"issue":"2","key":"10.1016\/j.beem.2021.101487_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-20-0380","article-title":"Etomidate infusion at low doses is an effective and safe treatment for severe Cushing\u2019 s syndrome outside intensive care","volume":"183","author":"Constantinescu","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2021.101487_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-020-01277-0","article-title":"Osilodrostat: first approval","volume":"80","author":"Duggan","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.beem.2021.101487_bib33","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1530\/EJE-20-0557","article-title":"Letter to the Editor\u00a0: efficacy and tolerance of osilodrostat in patients with severe Cushing\u2019s syndrome due to non-pituitary cancers","volume":"183","author":"Haissaguerre","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2021.101487_bib34","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","article-title":"Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing\u2019s syndrome","volume":"96","author":"Kamenick\u00fd","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2021.101487_bib35","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-18-1014","article-title":"Cabergoline in severe ectopic or occult Cushing\u2019s syndrome","volume":"181","author":"Ilie","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"19","key":"10.1016\/j.beem.2021.101487_bib36","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJMc1000094","article-title":"Pasireotide alone or with cabergoline and ketoconazole in Cushing\u2019s disease","volume":"362","author":"Feelders","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.beem.2021.101487_bib37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A\u00a012-month phase 3 study of pasireotide in Cushing\u2019s disease","volume":"366","author":"Colao","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.beem.2021.101487_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12020-015-0601-2","article-title":"Clinical management of critically ill patients with Cushing\u2019s disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide","volume":"52","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2021.101487_bib39","first-page":"16","article-title":"Efficacy of pasireotide in controlling severe hypercortisolism until cardiac transplantation","volume":"2017","author":"Attanasio","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"6","key":"10.1016\/j.beem.2021.101487_bib40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1530\/EJE-09-0098","article-title":"Merits and pitfalls of mifepristone in Cushing\u2019s syndrome","volume":"160","author":"Castinetti","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2021.101487_bib41","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/BF03350817","article-title":"Treatment of severe psychosis due to ectopic Cushing\u2019s syndrome","volume":"30","author":"Bilgin","year":"2007","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.beem.2021.101487_bib42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-14-0913","article-title":"Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole","volume":"172","author":"Corcuff","year":"2015","journal-title":"Eur J Endocrinol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2100004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2100004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:57:10Z","timestamp":1761497830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X2100004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1521690X2100004X"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101487","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical therapy in severe hypercortisolism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101487"}}